TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 2 | 6 | 6 | 7 | 27 | 31 | 13 |
| P | %wins | 100 | 100 | 75 | 50 | 75 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/8/10 18:40 | 6/4/10 | SGEN | Seattle Genetics Inc /wa | DE | Health | BioPrd | Biological Products, (No Diag | Lippman Marc E | WA | D | P | 250 | 12.49 | 12 | 20 | 24 | 104 | D | 29 | 15 | 25 | 0 | 2 | -8 | -6 | -11 | 1 | 8 | 2 | 4 | 33 | 63 | |
5/12/10 18:29 | 5/10/10 | SGEN | Seattle Genetics Inc /wa | DE | Health | BioPrd | Biological Products, (No Diag | Lippman Marc E | WA | D | P | 132 | 11.92 | 9 | 11 | 15 | 84 | D | 30 | 45 | 35 | 33 | 6 | 12 | 1 | 10 | 1 | 1 | -4 | -3 | 13 | 36 | |
9/20/07 19:09 | 9/17/07 | SGEN | Seattle Genetics Inc /wa | DE | Health | BioPrd | Biological Products, (No Diag | Lippman Marc E | WA | D | P | 21 | 10.62 | 4 | 2 | 3 | 68 | I | 106 | 146 | 35 | 12 | 19 | 6 | 6 | 5 | 1 | 2 | 8 | -6 | -24 | 10 | |
8/15/03 16:47 | 8/14/03 | SGEN | Seattle Genetics Inc /wa | DE | Health | BioPrd | Biological Products, (No Diag | Lippman Marc E | MI | D | P | 73 | 4.88 | 1 | 15 | 40 | 53 | M | -10 | 57 | 63 | 30 | -1 | 2 | 12 | 10 | 4 | 12 | 17 | 32 | 85 | 16 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |